Move to topTop
March 27, 2012

Terumo Corporation announced today that it has established "Terumo Asia Holdings Pte. Ltd.", in Singapore as a holding company to manage operations in the rapidly growing Asian region and will begin its operation from April 1, 2012.

The Asian region is expected to increase its borderlessness in the future, as indicated by the progressive elimination of tariffs among some countries, in relation to plans to establish the ASEAN Economic Community by 2015. Furthermore, healthcare services are undergoing changes as seen from the progression of the collaborated effort of medical institutions and physicians across national borders.

Under these circumstances, Terumo is to reorganize its sales subsidiaries based in a total of seven countries-- the Philippines, Thailand, Indonesia, Singapore, Malaysia, Australia, and Vietnam*1--under the umbrella of this holding company. In this way, Terumo intends to secure a sustainable growth by promoting agile regional business strategy through tying up with local companies for example, and streamlining the logistics.

  • *1: After April, current branch offices in Singapore, Malaysia, and Australia, will be transferred to the local sales subsidiary companies. In Vietnam, a new local sales subsidiary company is to be established.

Terumo has previously established holding companies in the United States and China. Terumo strives to accelerate growth with global business strategies in accordance with the respective regional market characteristics.

Overview of the new company

Name: Terumo Asia Holdings Pte. Ltd.
Location: Singapore
Capitalization at the time of establishment: 900,000 Singapore dollars
Ownership: 100% by Terumo Corporation

About Terumo

Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 28,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.


Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.